Connect Biopharma Holdings Ltd
Connect Biopharma is a clinical-stage company developing rademikibart, an antibody targeting IL-4Rα for acute exacerbations of asthma and COPD.
8-KSep 30Latest SEC filing
Sep 30Latest story
Sign inSign inConnect Biopharma is a clinical-stage company developing rademikibart, an antibody targeting IL-4Rα for acute exacerbations of asthma and COPD.